drugset / Trial / NCT01122264
A Study in Patients With Erectile Dysfunction
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate if treatment in erectile dysfunction with a long-acting drug (Tadalafil) taken once a day or taken as needed results in a longer treatment adherence and better long term outcomes (over 24 weeks), compared with a short-acting drug (Sildenafil Citrate) taken as needed.
Timeline
- Start
- 2010-05
- Primary completion
- 2011-06
- Completion
- 2011-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Sildenafil | Unknown | 25 mg | Oral |
| Comparator | Sildenafil | Unknown | 50 mg | Oral |
| Comparator | Sildenafil | Unknown | 100 mg | Oral |
| Subject | Tadalafil | Small molecule | 2.5 mg | Oral |
| Subject | Tadalafil | Small molecule | 5 mg | Oral |
| Subject | Tadalafil | Small molecule | 10 mg | Oral |
| Subject | Tadalafil | Small molecule | 20 mg | Oral |